A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

August 31, 2010

Conditions
AtherosclerosisCoronary Artery Disease
Interventions
DEVICE

PROMUS Element™

Drug eluting coronary stent system

Trial Locations (17)

2010

St. Vincent's Hospital - Sydney, Darlinghurst

2065

Royal North Shore Hospital, St Leonards

2170

Liverpool Hospital, Liverpool

3065

St. Vincent Hospital (Melbourne), Fitzroy

3168

Monash Medical Centre, Clayton

4032

The Prince Charles Hospital, Brisbane

5000

Royal Adelaide Hospital, Adelaide

6009

Sir Charles Gairdner Hospital, Perth

6160

Fremantle Hospital, Fremantle

8001

Christchurch Hospital, Christchurch

9001

Dunedin Hospital, Dunedin

50400

Institut Jantung Negara, Kuala Lumpur

119074

National University Hospital, Singapore, Singapore

168752

National Heart Centre Singapore, Singapore

Unknown

Middlemore Hospital, Otahuhu

Wellington Hospital, Wellington

0622

North Shore Hospital, Takapuna

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY